Biotecnología
Biotecnología
CureVac Names New Chief Business Officer
25/04/2024 -
Thaminda Ramanayake offers more than 15 years of biopharma development and deal-making experience.
RevolKa and La Jolla Institute Partner to Create Antigens for Next-Gen Vaccines
22/04/2024 -
Aim to address unmet medical needs in infectious diseases.
CureVac, MD Anderson Enter Strategic Cancer Vax Pact
17/04/2024 -
Aims to develop differentiated cancer vaccine candidates in selected hematological and solid tumor indications.
FUJIFILM Corporation Invests $1.2B in Holly Springs, NC Facility
16/04/2024 -
Aims to further expand the planned FUJIFILM Diosynth Biotechnologies end-to-end bio-manufacturing facility.
Soligenix Granted FDA Orphan Drug Designation for SuVax Active Ingredient
16/04/2024 -
The SuVax vaccine specifically addresses the potentially lethal Sudan Virus Disease, caused by SUDV.
Considerations for Developmental Toxicity Studies for Preventive and Therapeutic Vaccines for Infectious Disease Indications
16/04/2024 -
This is Guidance for Industry: Considerations for Developmental Toxicity Studies for Preventive and Therapeutic Vaccines for Infectious Disease Indications, CBER, Biologics
Viatris Welcomes Corinne Le Goff as Chief Commercial Officer
16/04/2024 -
Le Goff is a biotechnology and pharmaceutical executive with more than 25 years of experience leading and building teams globally.
KBI Biopharma Names JB Agnus as Chief Business Officer
16/04/2024 -
Agnus brings more than two decades of experience across various sectors of the biopharmaceutical industry.
Session at AAPS National Biotechnology Conference to Cover Gene & Therapy Market
16/04/2024 -
‘Cell and Gene Therapies at the Intersection of Business and Science,’ will take place on May 14 at 9:30 a.m. in San Francisco.
Waters Corporation Introduces Alliance iS BioHPLC System
10/04/2024 -
The new system is designed to help biopharma QC analysts boost efficiency and eliminate up to 40% of common errors.
Kintara Therapeutics and TuHURA Biosciences to Merge
04/04/2024 -
The combined company will focus on advancing TuHURA's personalized cancer vaccines and first-in-class bi-functional ADCS.
Prozomix, Ginkgo Bioworks Partner to Build Out Production of Next-Gen Enzyme Plates
04/04/2024 -
The partnership combines Ginkgo's AI/ML and enzyme engineering expertise with Prozomix's wealth of enzyme sequence data.
ProBioGen Partners with DIOSynVax to Manufacture Trivalent Hemorrhagic Fever Vaccine
03/04/2024 -
The novel vaccine targets HF diseases caused by Ebola, Marburg, and Lassa viruses.
Intravacc and Primrose Bio Partner to Enhance Conjugate Vaccine Development
03/04/2024 -
Will leverage their combined experience in the development of conjugate vaccines to offer a seamless solution.
KBI Biopharma Welcomes Peter Carbone as Chief Quality Officer
03/04/2024 -
Carbone brings 35+ years of experience in operations, quality, and technology leadership in a diverse range of areas in the life sciences spectrum.
Kemwell BioPharma Implements Veeva QMS
03/04/2024 -
Aims to drive quality excellence across its development and manufacturing operations with the cloud-based platform.
BioNTech Faces NIH Heat: Notice of Default Issued Over COVID-19 Vaccine Royalties
27/03/2024 -
BioNTech intends to vigorously defend itself against all allegations of breach.
AbbVie Agrees to Acquire Landos Biopharma
26/03/2024 -
Aims to advance the clinical development of NX-13, a differentiated, first-in-class, oral asset.
Altamira, Univercells Partner on Nanoparticle-Delivered mRNA Vaccines
26/03/2024 -
Univercells will test in vitro and in vivo a proprietary mRNA vaccine delivered with Altamira’s SemaPhore nanoparticle platform.
AAPS Reveals Opening & Closing Plenary Speakers for 2024 National Biotechnology Conference
18/03/2024 -
Hari Pujar, Ph.D., M.B.A. will deliver the opening plenary and Peter Lee, Ph.D. will deliver the closing plenary.
